Looks like the market likes the changes okay so far. The stock's now double its recent low point.
This stuff's going to wreak havoc on the Speculation component of the IW in a few more weeks!
As my Boy Scout leader taught us:
BE PREPARED!!!
Best regards, Tom
Recent ADCT News
- ADC Therapeutics Makes Grants to New Employees Under Inducement Plan • GlobeNewswire Inc. • 05/01/2024 08:05:00 PM
- ADC Therapeutics to Host First Quarter 2024 Financial Results and Pipeline Update Conference Call on May 6, 2024 • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Glofitamab or Mosunetuzumab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma • GlobeNewswire Inc. • 04/04/2024 11:00:00 AM
- ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024 • GlobeNewswire Inc. • 04/03/2024 11:00:00 AM
- ADC Therapeutics Makes Grants to New Employees Under Inducement Plan • GlobeNewswire Inc. • 04/01/2024 08:05:00 PM
- Mixed Futures Amidst Quiet Economic Schedule; Oil Prices Climb • IH Market News • 03/13/2024 11:03:39 AM
- ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 03/13/2024 11:00:00 AM
- ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes Summit • GlobeNewswire Inc. • 03/06/2024 12:15:00 PM
- ADC Therapeutics to Host Fourth Quarter and Year-End 2023 Financial Results Conference Call on March 13, 2024 • GlobeNewswire Inc. • 03/06/2024 12:00:00 PM
- ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) Annual Meeting • GlobeNewswire Inc. • 03/05/2024 10:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 02:15:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:30:37 PM
- ADC Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/27/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 01:00:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:30:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 12:15:54 PM
- ADC Therapeutics Regains Compliance with NYSE Continued Listing Standards • GlobeNewswire Inc. • 01/04/2024 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 12:00:30 PM
- ADC Therapeutics Provides Business Updates • GlobeNewswire Inc. • 01/04/2024 12:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 01:10:56 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 01:05:58 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 01:04:44 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 01:00:16 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 12:59:46 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 12:58:50 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM